{"id":"https://openalex.org/W1978005566","doi":"https://doi.org/10.1111/j.1365-2982.2009.01270.x","title":"GSK962040: a small molecule, selective motilin receptor agonist, effective as a stimulant of human and rabbit gastrointestinal motility","display_name":"GSK962040: a small molecule, selective motilin receptor agonist, effective as a stimulant of human and rabbit gastrointestinal motility","alternate_titles":[],"publication_year":2009,"publication_date":"2009-05-20","ids":{"openalex":"https://openalex.org/W1978005566","doi":"https://doi.org/10.1111/j.1365-2982.2009.01270.x","mag":"1978005566","pmid":"https://pubmed.ncbi.nlm.nih.gov/19374732"},"language":"en","primary_location":{"id":"doi:10.1111/j.1365-2982.2009.01270.x","doi":"https://doi.org/10.1111/j.1365-2982.2009.01270.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2982.2009.01270.x","pdf_url":null,"source":{"id":"https://openalex.org/S84837402","display_name":"Neurogastroenterology & Motility","issn_l":"1350-1925","issn":["1350-1925","1365-2982"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurogastroenterology &amp; Motility","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1978005566"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048726120","display_name":"Gareth John Sanger","orcid":"https://orcid.org/0000-0002-4231-1945","observed_orcids":["https://orcid.org/0000-0002-4231-1945"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"G. J. Sanger","raw_affiliation_strings":["Immuno-Inflammation CEDD, GlaxoSmithKline, Stevenage, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immuno-Inflammation CEDD, GlaxoSmithKline, Stevenage, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060261159","display_name":"Susan M. Westaway","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S. M. Westaway","raw_affiliation_strings":["Immuno-Inflammation CEDD, GlaxoSmithKline, Stevenage, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immuno-Inflammation CEDD, GlaxoSmithKline, Stevenage, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045267805","display_name":"Ashley A. Barnes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A. A. Barnes","raw_affiliation_strings":["Biochemical Cell Targets, GlaxoSmithKline, Stevenage, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biochemical Cell Targets, GlaxoSmithKline, Stevenage, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052249595","display_name":"David T. MacPherson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"D. T. Macpherson","raw_affiliation_strings":["Neuroscience CEDD, GlaxoSmithKline, Harlow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroscience CEDD, GlaxoSmithKline, Harlow, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111092303","display_name":"Aaron Muir","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I4405268060","display_name":"GlaxoSmithKline Research & Development Limited (United Kingdom)","ror":"https://ror.org/05mayyh83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405268060"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A. I. Muir","raw_affiliation_strings":["Molecular Discovery Research, GlaxoSmithKline, Harlow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Discovery Research, GlaxoSmithKline, Harlow, UK","institution_ids":["https://openalex.org/I188950975","https://openalex.org/I4405268060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059581820","display_name":"Emma M. Jarvie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"E. M. Jarvie","raw_affiliation_strings":["Neuroscience CEDD, GlaxoSmithKline, Harlow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroscience CEDD, GlaxoSmithKline, Harlow, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020396687","display_name":"Victoria N. Bolton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"V. N. Bolton","raw_affiliation_strings":["Immuno-Inflammation CEDD, GlaxoSmithKline, Stevenage, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immuno-Inflammation CEDD, GlaxoSmithKline, Stevenage, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017136849","display_name":"Selim Cellek","orcid":"https://orcid.org/0000-0002-4856-285X","observed_orcids":["https://orcid.org/0000-0002-4856-285X"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S. Cellek","raw_affiliation_strings":["Immuno-Inflammation CEDD, GlaxoSmithKline, Stevenage, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immuno-Inflammation CEDD, GlaxoSmithKline, Stevenage, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034453769","display_name":"Erik B. N\u00e4slund","orcid":"https://orcid.org/0000-0002-0166-6344","observed_orcids":["https://orcid.org/0000-0002-0166-6344"]},"institutions":[{"id":"https://openalex.org/I2802208705","display_name":"Danderyds sjukhus","ror":"https://ror.org/00hm9kt34","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I2802208705","https://openalex.org/I28166907"]},{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"E. N\u00e4slund","raw_affiliation_strings":["Division of Surgery, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Surgery, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden","institution_ids":["https://openalex.org/I2802208705","https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068473291","display_name":"Per M. Hellstr\u00f6m","orcid":"https://orcid.org/0000-0001-8428-0772","observed_orcids":["https://orcid.org/0000-0001-8428-0772"]},"institutions":[{"id":"https://openalex.org/I1335113835","display_name":"Karolinska University Hospital","ror":"https://ror.org/00m8d6786","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1335113835"]},{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P. M. Hellstr\u00f6m","raw_affiliation_strings":["Department of Medicine, Karolinska University Hospital, Solna, Karolinska Institutet, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Karolinska University Hospital, Solna, Karolinska Institutet, Stockholm, Sweden","institution_ids":["https://openalex.org/I1335113835","https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108312637","display_name":"R. A. Borman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R. A. Borman","raw_affiliation_strings":["Immuno-Inflammation CEDD, GlaxoSmithKline, Stevenage, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immuno-Inflammation CEDD, GlaxoSmithKline, Stevenage, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012347274","display_name":"William P. Unsworth","orcid":"https://orcid.org/0000-0002-9169-5156","observed_orcids":["https://orcid.org/0000-0002-9169-5156"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"W. P. Unsworth","raw_affiliation_strings":["Immuno-Inflammation CEDD, GlaxoSmithKline, Stevenage, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immuno-Inflammation CEDD, GlaxoSmithKline, Stevenage, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109945672","display_name":"Kim L. Matthews","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"K. L. Matthews","raw_affiliation_strings":["Neuroscience CEDD, GlaxoSmithKline, Harlow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroscience CEDD, GlaxoSmithKline, Harlow, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110389150","display_name":"K. Lee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"K. Lee","raw_affiliation_strings":["Immuno-Inflammation CEDD, GlaxoSmithKline, Stevenage, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immuno-Inflammation CEDD, GlaxoSmithKline, Stevenage, UK","institution_ids":["https://openalex.org/I188950975"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5048726120"],"corresponding_institution_ids":["https://openalex.org/I188950975"],"apc_list":{"value":4640,"currency":"USD","value_usd":4640},"apc_paid":null,"fwci":7.3816,"has_fulltext":false,"cited_by_count":80,"citation_normalized_percentile":{"value":0.9701659,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"21","issue":"6","first_page":"657","last_page":"657"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10365","display_name":"Gastrointestinal motility and disorders","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10365","display_name":"Gastrointestinal motility and disorders","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/motilin-receptor-agonist","display_name":"motilin receptor agonist","score":0.9850000143051147},{"id":"https://openalex.org/keywords/gastric-emptying","display_name":"gastric emptying","score":0.7789999842643738},{"id":"https://openalex.org/keywords/gastrointestinal-motility","display_name":"gastrointestinal motility","score":0.7699999809265137},{"id":"https://openalex.org/keywords/gastroparesis","display_name":"gastroparesis","score":0.8069999814033508},{"id":"https://openalex.org/keywords/erythromycin","display_name":"erythromycin","score":0.9729999899864197},{"id":"https://openalex.org/keywords/metoclopramide","display_name":"metoclopramide","score":0.7329999804496765},{"id":"https://openalex.org/keywords/cholinergic-contraction","display_name":"cholinergic contraction","score":0.5809999704360962},{"id":"https://openalex.org/keywords/fecal-output","display_name":"fecal output","score":0.7590000033378601},{"id":"https://openalex.org/keywords/receptor-selectivity","display_name":"receptor selectivity","score":0.6740000247955322},{"id":"https://openalex.org/keywords/small-molecule-agonists","display_name":"small molecule agonists","score":0.5519999861717224}],"concepts":[{"id":"https://openalex.org/C131793682","wikidata":"https://www.wikidata.org/wiki/Q126440","display_name":"Motilin","level":2,"score":0.944629967212677},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.7765311002731323},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.6143368482589722},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6112409830093384},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5737355351448059},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5104405283927917},{"id":"https://openalex.org/C3020479747","wikidata":"https://www.wikidata.org/wiki/Q1029907","display_name":"Gastric emptying","level":3,"score":0.46111324429512024},{"id":"https://openalex.org/C2780206985","wikidata":"https://www.wikidata.org/wiki/Q213511","display_name":"Erythromycin","level":3,"score":0.44681787490844727},{"id":"https://openalex.org/C58732023","wikidata":"https://www.wikidata.org/wiki/Q770260","display_name":"Partial agonist","level":4,"score":0.4149152934551239},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4085240066051483},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.34793490171432495},{"id":"https://openalex.org/C2779422922","wikidata":"https://www.wikidata.org/wiki/Q1029907","display_name":"Stomach","level":2,"score":0.2684735059738159},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.21175125241279602},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1313457489013672},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.06890305876731873}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003672","descriptor_name":"Defecation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004558","descriptor_name":"Electric Stimulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004917","descriptor_name":"Erythromycin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005769","descriptor_name":"Gastrointestinal Motility","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009037","descriptor_name":"Motilin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D009037","descriptor_name":"Motilin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010275","descriptor_name":"Parasympathetic Nervous System","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011706","descriptor_name":"Pyloric Antrum","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011817","descriptor_name":"Rabbits","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011964","descriptor_name":"Receptors, Gastrointestinal Hormone","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013268","descriptor_name":"Stimulation, Chemical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013379","descriptor_name":"Substrate Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016473","descriptor_name":"Gallbladder Emptying","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018013","descriptor_name":"Receptors, Neuropeptide","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D066298","descriptor_name":"In Vitro Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1365-2982.2009.01270.x","doi":"https://doi.org/10.1111/j.1365-2982.2009.01270.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2982.2009.01270.x","pdf_url":null,"source":{"id":"https://openalex.org/S84837402","display_name":"Neurogastroenterology & Motility","issn_l":"1350-1925","issn":["1350-1925","1365-2982"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurogastroenterology &amp; Motility","raw_type":"journal-article"},{"id":"pmid:19374732","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19374732","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurogastroenterology and motility","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8371999859809875,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320322315","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691"},{"id":"https://openalex.org/F4320322581","display_name":"Vetenskapsr\u00e5det","ror":"https://ror.org/03zttf063"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":44,"referenced_works":["https://openalex.org/W164555988","https://openalex.org/W1559337784","https://openalex.org/W1753409279","https://openalex.org/W1950823066","https://openalex.org/W1964454828","https://openalex.org/W1969092193","https://openalex.org/W1972816241","https://openalex.org/W1976927874","https://openalex.org/W1977331693","https://openalex.org/W1978416618","https://openalex.org/W1984337174","https://openalex.org/W1987390388","https://openalex.org/W2003387346","https://openalex.org/W2006822351","https://openalex.org/W2011505010","https://openalex.org/W2011599665","https://openalex.org/W2014965206","https://openalex.org/W2015568660","https://openalex.org/W2022236220","https://openalex.org/W2023430191","https://openalex.org/W2024554273","https://openalex.org/W2036423003","https://openalex.org/W2038784474","https://openalex.org/W2062062781","https://openalex.org/W2064019454","https://openalex.org/W2068310771","https://openalex.org/W2074184415","https://openalex.org/W2075722316","https://openalex.org/W2082746725","https://openalex.org/W2085683872","https://openalex.org/W2086085808","https://openalex.org/W2086637422","https://openalex.org/W2092253259","https://openalex.org/W2100897424","https://openalex.org/W2105231848","https://openalex.org/W2118949657","https://openalex.org/W2139840334","https://openalex.org/W2140126757","https://openalex.org/W2141466583","https://openalex.org/W2162628083","https://openalex.org/W2164085009","https://openalex.org/W2360571137","https://openalex.org/W2401447847","https://openalex.org/W4211244827"],"related_works":["https://openalex.org/W1825401738","https://openalex.org/W1891085103","https://openalex.org/W4213217805","https://openalex.org/W2287613769","https://openalex.org/W1753409279","https://openalex.org/W2027606442","https://openalex.org/W2208410917","https://openalex.org/W1527905822","https://openalex.org/W1981752951","https://openalex.org/W1530606127"],"abstract_inverted_index":{"There":[0],"is":[1],"an":[2,36],"urgent":[3],"clinical":[4],"need":[5],"for":[6,128,265],"a":[7,56,145,167,178,231,240],"safe,":[8],"efficacious":[9],"stimulant":[10],"of":[11,54,112,118,123,147,170,173,180,208,216,249,261],"gastric":[12,158],"emptying;":[13],"current":[14],"therapies":[15],"include":[16],"erythromycin":[17,131,195,225],"(an":[18],"antibiotic":[19],"with":[20,43],"additional":[21],"properties":[22],"which":[23],"preclude":[24],"chronic":[25],"use)":[26],"and":[27,35,65,76,86,130,137,154,199],"metoclopramide":[28],"(a":[29],"5-hydroxytryptamine":[30],"type":[31],"4":[32],"receptor":[33,60,256],"agonist":[34,119],"antagonist":[37],"at":[38,144,184],"brain":[39],"D2":[40],"receptors,":[41,74],"associated":[42],"movement":[44],"disorders).":[45],"To":[46],"move":[47],"away":[48],"from":[49],"the":[50,100,104,113,116,124,171,245,250,259],"complex":[51],"motilide":[52],"structure":[53],"erythromycin,":[55],"small":[57],"molecule":[58],"motilin":[59,85,102,246],"agonist,":[61],"GSK962040,":[62,239],"was":[63,69],"identified":[64],"characterized.":[66],"The":[67],"compound":[68],"evaluated":[70],"using":[71],"recombinant":[72],"human":[73,77,101],"rabbit":[75,157],"isolated":[78],"stomach":[79],"preparations":[80],"known":[81],"to":[82,84,93,109,177,253],"respond":[83],"in":[87,96],"vivo,":[88],"by":[89],"measuring":[90],"its":[91],"ability":[92],"increase":[94],"defecation":[95],"conscious":[97,212],"rabbits.":[98],"At":[99],"receptor,":[103],"pEC50":[105],"(the":[106],"negative":[107],"logarithm":[108],"base":[110],"10":[111,192,196,222],"EC50":[114],"value,":[115],"concentration":[117],"that":[120,238],"produces":[121],"50%":[122],"maximal":[125],"response)":[126],"values":[127],"GSK962040":[129,139,160,191,220],"as":[132],"agonists":[133],"were,":[134],"respectively,":[135],"7.9":[136],"7.3;":[138],"had":[140],"no":[141],"significant":[142],"activity":[143],"range":[146],"other":[148],"receptors":[149],"(including":[150],"ghrelin),":[151],"ion":[152],"channels":[153],"enzymes.":[155],"In":[156,188,211],"antrum,":[159],"300":[161],"nmol":[162,202],"L(-1)-10":[163],"micromol":[164,186,193,197],"L(-1)":[165,198],"caused":[166,205],"prolonged":[168],"facilitation":[169],"amplitude":[172],"cholinergically":[174],"mediated":[175],"contractions,":[176],"maximum":[179],"248":[181],"+/-":[182],"47%":[183],"3":[185],"L(-1).":[187],"human-isolated":[189],"stomach,":[190],"L(-1),":[194,203],"[Nle13]-motilin":[200],"100":[201],"each":[204],"muscle":[206],"contraction":[207],"similar":[209],"amplitude.":[210],"rabbits,":[213],"intravenous":[214],"doses":[215],"5":[217],"mg":[218,223],"kg(-1)":[219,224],"or":[221],"significantly":[226],"increased":[227],"faecal":[228],"output":[229],"over":[230],"2-h":[232],"period.":[233],"Together,":[234],"these":[235],"data":[236],"show":[237],"non-motilide":[241],"structure,":[242],"selectively":[243],"activates":[244],"receptor.":[247],"Simplification":[248],"structural":[251],"requirements":[252],"activate":[254],"this":[255],"greatly":[257],"facilitates":[258],"design":[260],"potentially":[262],"new":[263],"medicines":[264],"gastroparesis.":[266]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1978005566","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":4},{"year":2023,"cited_by_count":3},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":11},{"year":2012,"cited_by_count":9}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
